147 related articles for article (PubMed ID: 37181811)
1. Comprehensive Analysis of the Expression, Prognostic Value, and Immune Infiltration Activities of GABRD in Colon Adenocarcinoma.
Huang F; Wang Z; Zhu L; Lin C; Wang JX
Mediators Inflamm; 2023; 2023():8709458. PubMed ID: 37181811
[TBL] [Abstract][Full Text] [Related]
2. A Prognostic Model Based on the Immune-related Genes in Colon Adenocarcinoma.
Sun YL; Zhang Y; Guo YC; Yang ZH; Xu YC
Int J Med Sci; 2020; 17(13):1879-1896. PubMed ID: 32788867
[No Abstract] [Full Text] [Related]
3. Analysis of Interleukin-1 Signaling Alterations of Colon Adenocarcinoma Identified Implications for Immunotherapy.
Zhou X; Liu Y; Xiang J; Wang Y; Wang Q; Xia J; Chen Y; Bai Y
Front Immunol; 2021; 12():665002. PubMed ID: 34367132
[TBL] [Abstract][Full Text] [Related]
4. Identification prognosis-associated immune genes in colon adenocarcinoma.
Miao Y; Wang J; Ma X; Yang Y; Mi D
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33140821
[TBL] [Abstract][Full Text] [Related]
5. INHBA is a prognostic predictor for patients with colon adenocarcinoma.
Li X; Yu W; Liang C; Xu Y; Zhang M; Ding X; Cai X
BMC Cancer; 2020 Apr; 20(1):305. PubMed ID: 32293338
[TBL] [Abstract][Full Text] [Related]
6. Enhanced expression of GABRD predicts poor prognosis in patients with colon adenocarcinoma.
Wu M; Kim KY; Park WC; Ryu HS; Choi SC; Kim MS; Myung JY; Choi HS; Kim EJ; Lee MY
Transl Oncol; 2020 Dec; 13(12):100861. PubMed ID: 32891902
[TBL] [Abstract][Full Text] [Related]
7. Research for Expression and Prognostic Value of GABRD in Colon Cancer and Coexpressed Gene Network Construction Based on Data Mining.
Liu T; Fang Y
Comput Math Methods Med; 2021; 2021():5544182. PubMed ID: 34194536
[TBL] [Abstract][Full Text] [Related]
8. Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma.
Liu C; Liu D; Wang F; Liu Y; Xie J; Xie J; Xie Y
Front Immunol; 2022; 13():1038927. PubMed ID: 36451813
[TBL] [Abstract][Full Text] [Related]
9. Exploration of the relationship between tumor mutation burden and immune infiltrates in colon adenocarcinoma.
Ouyang R; Li Z; Peng P; Zhang J; Liu J; Qin M; Huang J
Int J Med Sci; 2021; 18(3):685-694. PubMed ID: 33437203
[No Abstract] [Full Text] [Related]
10. Investigating gene signatures associated with immunity in colon adenocarcinoma to predict the immunotherapy effectiveness using NFM and WGCNA algorithms.
Liang W; Yang X; Li X; Wang P; Zhu Z; Liu S; Xu D; Zhi X; Xue J
Aging (Albany NY); 2024 May; 16(9):7596-7621. PubMed ID: 38742936
[TBL] [Abstract][Full Text] [Related]
11. A Comprehensive Prognostic Model for Colon Adenocarcinoma Depending on Nuclear-Mitochondrial-Related Genes.
Lv L; Huang Y; Li Q; Wu Y; Zheng L
Technol Cancer Res Treat; 2024; 23():15330338241258570. PubMed ID: 38832431
[No Abstract] [Full Text] [Related]
12. Establishment of an immune-related gene pair model to predict colon adenocarcinoma prognosis.
Luo J; Liu P; Wang L; Huang Y; Wang Y; Geng W; Chen D; Bai Y; Yang Z
BMC Cancer; 2020 Nov; 20(1):1071. PubMed ID: 33167940
[TBL] [Abstract][Full Text] [Related]
13. Clinical Data and Biocalculation Methods of GABRD Determine the Clinical Characteristics and Immune Relevance of Colorectal Cancer.
Bi Y; Liu X; Li W; Xu J; Xi J; Wei S
Evid Based Complement Alternat Med; 2022; 2022():6198448. PubMed ID: 35774742
[TBL] [Abstract][Full Text] [Related]
14. A novel signature model based on mitochondrial-related genes for predicting survival of colon adenocarcinoma.
Gao H; Xing F
BMC Med Inform Decis Mak; 2022 Oct; 22(1):277. PubMed ID: 36273131
[TBL] [Abstract][Full Text] [Related]
15. Multi-Omics Reveal the Immunological Role and the Theragnostic Value of miR-216a/GDF15 Axis in Human Colon Adenocarcinoma.
Tung CB; Li CY; Lin HY
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948431
[TBL] [Abstract][Full Text] [Related]
16. Identification of a Four-Gene Metabolic Signature to Evaluate the Prognosis of Colon Adenocarcinoma Patients.
Zheng Y; Wu R; Wang X; Yin C
Front Public Health; 2022; 10():860381. PubMed ID: 35462848
[TBL] [Abstract][Full Text] [Related]
17. Circadian Clock Genes Are Correlated with Prognosis and Immune Cell Infiltration in Colon Adenocarcinoma.
He A; Huang Z; Zhang R; Lu H; Wang J; Cao J; Feng Q
Comput Math Methods Med; 2022; 2022():1709918. PubMed ID: 35116071
[TBL] [Abstract][Full Text] [Related]
18. INSC Is a Prognosis-Associated Biomarker Involved in Tumor Immune Infiltration in Colon Adenocarcinoma.
Zhaoran S; Weidong J
Biomed Res Int; 2022; 2022():5794150. PubMed ID: 36132082
[TBL] [Abstract][Full Text] [Related]
19. A potential prognostic prediction model of colon adenocarcinoma with recurrence based on prognostic lncRNA signatures.
Jin L; Li C; Liu T; Wang L
Hum Genomics; 2020 Jun; 14(1):24. PubMed ID: 32522293
[TBL] [Abstract][Full Text] [Related]
20. Development of a prognostic model for personalized prediction of colon adenocarcinoma (COAD) patient outcomes using methylation-driven genes.
Chen D; Zhang B; Kang K; Li L; Liao Y; Qing S; Di Y
J Appl Genet; 2023 Dec; 64(4):713-721. PubMed ID: 37589877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]